
LINK . SPRINGER . COM {
}
Title:
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients | Breast Cancer Research and Treatment
Description:
Currently used methods to detect and enumerate circulating tumor cells (CTCs) rely on the expression of the epithelial cell adhesion molecule (EpCAM) and cytokeratins. This selection may exclude cells that have undergone intrinsic modifications of their phenotype, as epithelial-mesenchymal transition (EMT). Aim of the study was to investigate the expression of EMT and stemness markers in CTCs from breast cancer patients in all stages of disease. 92 female breast cancer patients were enrolled. CTCs were isolated by CELLection™ Dynabeads® coated with the monoclonal antibody toward EpCam. Samples found positive for CTCs presence (CD45−/CK+) were evaluated for the expression of ER alpha, HER2, ALDH1, vimentin, and fibronectin. Samples negative for CTCs presence (CD45−/CK−) were also evaluated for the expression of vimentin and fibronectin, used as markers of EMT. CTCs were found in 66% of patients. The distribution of CTCs presence according to stage and grade of disease was found statistically significant. The expression of ALDH1 on CTCs was found to correlate to stage of disease and to the expression of vimentin and fibronectin. In 34% of patients, we detected cells with negative CK/CD45 expression but positive expression of vimentin and fibronectin. There is an urgent need for optimizing CTCs detection methods through the inclusion of EMT markers. The detection of cells in mesenchymal transition, retaining EMT and stemness features, may contribute to discover additional therapeutic targets useful to eradicate micrometastatic disease in breast cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Health & Fitness
- Science
- Education
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,603,724 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We don't see any clear sign of profit-making.
Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.
Keywords {🔍}
cancer, article, cells, breast, google, scholar, pubmed, cas, circulating, tumor, transition, patients, ctcs, expression, epithelialmesenchymal, stem, cell, emt, disease, detection, access, res, rome, research, mesenchymal, privacy, cookies, content, stemness, gazzaniga, epithelial, publish, search, study, raimondi, gradilone, naso, cortesi, epcam, markers, found, vimentin, fibronectin, discover, metastatic, open, molecular, cristofanilli, clinical, pantel,
Topics {✒️}
cancer stem cells month download article/chapter stem cell signaling epithelial–mesenchymal transition markers epithelial-mesenchymal transition epithelial mesenchymal transition node-positive breast cancer disseminated tumor cells circulating tumor cells metastatic breast cancer circulating cancer cells high ep-cam expression negative ck/cd45 expression disseminating tumour cells full article pdf related subjects mesenchymal transition privacy choices/manage cookies circulating tumour cell breast cancer patients human breast cancer eribulin-based treatment article raimondi paola gazzaniga check access instant access cancer research 69 european economic area undergone intrinsic modifications cellection™ dynabeads® coated hayes df specific biological properties international expert consensus chemosensitivity profile assay conditions privacy policy mesenchymal transitions meeting abstract supplement campus biomedico university electronic supplementary material exclude cells detected cells samples negative accepting optional cookies samples found positive found statistically significant bone marrow micrometastasis article log breast cancer eradicate micrometastatic disease journal finder publish
Schema {🗺️}
WebPage:
mainEntity:
headline:Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
description:Currently used methods to detect and enumerate circulating tumor cells (CTCs) rely on the expression of the epithelial cell adhesion molecule (EpCAM) and cytokeratins. This selection may exclude cells that have undergone intrinsic modifications of their phenotype, as epithelial-mesenchymal transition (EMT). Aim of the study was to investigate the expression of EMT and stemness markers in CTCs from breast cancer patients in all stages of disease. 92 female breast cancer patients were enrolled. CTCs were isolated by CELLection™ Dynabeads® coated with the monoclonal antibody toward EpCam. Samples found positive for CTCs presence (CD45−/CK+) were evaluated for the expression of ER alpha, HER2, ALDH1, vimentin, and fibronectin. Samples negative for CTCs presence (CD45−/CK−) were also evaluated for the expression of vimentin and fibronectin, used as markers of EMT. CTCs were found in 66% of patients. The distribution of CTCs presence according to stage and grade of disease was found statistically significant. The expression of ALDH1 on CTCs was found to correlate to stage of disease and to the expression of vimentin and fibronectin. In 34% of patients, we detected cells with negative CK/CD45 expression but positive expression of vimentin and fibronectin. There is an urgent need for optimizing CTCs detection methods through the inclusion of EMT markers. The detection of cells in mesenchymal transition, retaining EMT and stemness features, may contribute to discover additional therapeutic targets useful to eradicate micrometastatic disease in breast cancer.
datePublished:2011-02-05T00:00:00Z
dateModified:2011-02-05T00:00:00Z
pageStart:449
pageEnd:455
sameAs:https://doi.org/10.1007/s10549-011-1373-x
keywords:
Circulating tumor cells
Epithelial-mesenchymal transition
Cancer stem cells
Cytokeratins
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1373-x/MediaObjects/10549_2011_1373_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1373-x/MediaObjects/10549_2011_1373_Fig2_HTML.gif
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:130
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Cristina Raimondi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Angela Gradilone
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Giuseppe Naso
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Bruno Vincenzi
affiliation:
name:Campus Biomedico University of Rome
address:
name:Division of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Arianna Petracca
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Chiara Nicolazzo
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Antonella Palazzo
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Rosa Saltarelli
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Franco Spremberg
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Enrico Cortesi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Paola Gazzaniga
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
description:Currently used methods to detect and enumerate circulating tumor cells (CTCs) rely on the expression of the epithelial cell adhesion molecule (EpCAM) and cytokeratins. This selection may exclude cells that have undergone intrinsic modifications of their phenotype, as epithelial-mesenchymal transition (EMT). Aim of the study was to investigate the expression of EMT and stemness markers in CTCs from breast cancer patients in all stages of disease. 92 female breast cancer patients were enrolled. CTCs were isolated by CELLection™ Dynabeads® coated with the monoclonal antibody toward EpCam. Samples found positive for CTCs presence (CD45−/CK+) were evaluated for the expression of ER alpha, HER2, ALDH1, vimentin, and fibronectin. Samples negative for CTCs presence (CD45−/CK−) were also evaluated for the expression of vimentin and fibronectin, used as markers of EMT. CTCs were found in 66% of patients. The distribution of CTCs presence according to stage and grade of disease was found statistically significant. The expression of ALDH1 on CTCs was found to correlate to stage of disease and to the expression of vimentin and fibronectin. In 34% of patients, we detected cells with negative CK/CD45 expression but positive expression of vimentin and fibronectin. There is an urgent need for optimizing CTCs detection methods through the inclusion of EMT markers. The detection of cells in mesenchymal transition, retaining EMT and stemness features, may contribute to discover additional therapeutic targets useful to eradicate micrometastatic disease in breast cancer.
datePublished:2011-02-05T00:00:00Z
dateModified:2011-02-05T00:00:00Z
pageStart:449
pageEnd:455
sameAs:https://doi.org/10.1007/s10549-011-1373-x
keywords:
Circulating tumor cells
Epithelial-mesenchymal transition
Cancer stem cells
Cytokeratins
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1373-x/MediaObjects/10549_2011_1373_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1373-x/MediaObjects/10549_2011_1373_Fig2_HTML.gif
isPartOf:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:130
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Cristina Raimondi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Angela Gradilone
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Giuseppe Naso
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Bruno Vincenzi
affiliation:
name:Campus Biomedico University of Rome
address:
name:Division of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Arianna Petracca
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Chiara Nicolazzo
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Antonella Palazzo
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Rosa Saltarelli
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Franco Spremberg
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Enrico Cortesi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Paola Gazzaniga
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Breast Cancer Research and Treatment
issn:
1573-7217
0167-6806
volumeNumber:130
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Campus Biomedico University of Rome
address:
name:Division of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Cristina Raimondi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Angela Gradilone
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Giuseppe Naso
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Bruno Vincenzi
affiliation:
name:Campus Biomedico University of Rome
address:
name:Division of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Arianna Petracca
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Chiara Nicolazzo
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Antonella Palazzo
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Rosa Saltarelli
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
name:Franco Spremberg
affiliation:
name:Hospital “S. Giovanni Evangelista”
address:
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
type:PostalAddress
type:Organization
name:Enrico Cortesi
affiliation:
name:Sapienza University of Rome
address:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
name:Paola Gazzaniga
affiliation:
name:Sapienza University of Rome
address:
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
name:Division of Medical Oncology, Campus Biomedico University of Rome, Rome, Italy
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
name:Division of Medical Oncology, Hospital “S. Giovanni Evangelista”, Tivoli, Rome, Italy
name:Division of Medical Oncology, Sapienza University of Rome, Rome, Italy
name:Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(101)
- Learn how profitable https://www.springernature.com/gp/authors is on a monthly basis
- https://link.springernature.com/home/'s revenue stream
- https://order.springer.com/public/cart's revenue stream
- https://submission.springernature.com/new-submission/10549/3's total income per month
- What's the revenue for https://www.springernature.com/gp/librarians/licensing/agc/journals?
- How much profit does https://doi.org/10.1056%2FNEJMoa040766 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15317891 net monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%2C%20disease%20progression%2C%20and%20survival%20in%20metastatic%20breast%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa040766&volume=351&pages=781-791&publication_year=2004&author=Cristofanilli%2CM&author=Budd%2CGT&author=Ellis%2CMJ&author=Stopeck%2CA&author=Matera%2CJ&author=Miller%2CMC&author=Reuben%2CJM&author=Doyle%2CGV&author=Allard%2CWJ&author=Terstappen%2CLW&author=Hayes%2CDF generate?
- What's the monthly income of https://doi.org/10.1016%2Fj.ctrv.2009.03.004?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19410375?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%20%28CTCs%29%3A%20detection%20methods%20and%20their%20clinical%20relevance%20in%20breast%20cancer&journal=Cancer%20Treat%20Rev&doi=10.1016%2Fj.ctrv.2009.03.004&volume=35&pages=463-474&publication_year=2009&author=Mostert%2CB&author=Sleijfer%2CS&author=Foekens%2CJ&author=Gratama%2CJ
- How much income does https://doi.org/10.1038%2Fnrc2375 have?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18404148 gross monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=Detection%2C%20clinical%20relevance%20and%20specific%20biological%20properties%20of%20disseminating%20tumour%20cells&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2375&volume=8&pages=329-340&publication_year=2008&author=Pantel%2CK&author=Brakenhoff%2CRH&author=Brandt%2CB generate?
- https://doi.org/10.1159%2F000215581 income
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19407470 make?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Circulating%20and%20disseminated%20tumor%20cells%20in%20the%20clinical%20management%20of%20breast%20cancer%20patients%3A%20unanswered%20questions&journal=Oncology&doi=10.1159%2F000215581&volume=76&pages=375-386&publication_year=2009&author=Amadori%2CA&author=Rossi%2CE&author=Zamarchi%2CR&author=Carli%2CP&author=Pastorelli%2CD&author=Birillo%2CA generate?
- What are the earnings of https://doi.org/10.1158%2F1078-0432.CCR-05-2821?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16857794
- How much does http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%20at%20each%20follow-up%20time%20point%20during%20therapy%20of%20metastatic%20breast%20cancer%20patients%20predict%20progression-free%20and%20overall%20survival&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-2821&volume=12&pages=4218-4224&publication_year=2006&author=Hayes%2CDF&author=Cristofanilli%2CM&author=Budd%2CGT&author=Ellis%2CMJ&author=Stopeck%2CA&author=Miller%2CMC&author=Matera%2CJ&author=Allard%2CWJ&author=Doyle%2CGV&author=Terstappen%2CLW pull in monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=What%20goes%20around%2C%20comes%20around%3A%20a%20review%20of%20circulating%20tumor%20cells&journal=MLO%20Med%20Lab%20Obs&volume=32&pages=34-36&publication_year=2010&author=Gage%2CT&author=Fan%2CSL earns monthly
- How much does https://doi.org/10.1016%2Fj.gde.2009.12.002 bring in each month?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20071161?
- See how much http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%3A%20a%20window%20into%20cancer%20biology%20and%20metastasis&journal=Curr%20Opin%20Genet%20Dev&doi=10.1016%2Fj.gde.2009.12.002&volume=20&pages=96-99&publication_year=2010&author=Maheswaran%2CS&author=Haber%2CDA makes per month
- Explore the financials of https://doi.org/10.1111%2Fj.1349-7006.2009.01419.x
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19961486
- How much profit does http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20transition%20in%20cancer%20development%20and%20its%20clinical%20significance&journal=Cancer%20Sci&doi=10.1111%2Fj.1349-7006.2009.01419.x&volume=101&pages=293-299&publication_year=2010&author=Iwatsuki%2CM&author=Mimori%2CK&author=Yokobori%2CT&author=Ishi%2CH&author=Beppu%2CT&author=Nakamori%2CS&author=Baba%2CH&author=Mori%2CM make?
- https://doi.org/10.1093%2Fannonc%2Fmdm271's financial summary
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17675394?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Progress%20and%20promise%3A%20highlights%20of%20the%20international%20expert%20consensus%20on%20the%20primary%20therapy%20of%20early%20breast%20cancer%202007%20.10th%20St.%20Gallen%20conference&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdm271&volume=18&issue=7&pages=1133-1144&publication_year=2007&author=Goldhirsch%2CA&author=Wood%2CWC&author=Gelber%2CRD&author=Coates%2CAS&author=Th%C3%BCrlimann%2CB&author=Senn%2CHJ?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19821489 make?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Chemosensitivity%20profile%20assay%20of%20circulating%20cancer%20cells%3A%20prognostic%20and%20predictive%20value%20in%20epithelial%20tumors&journal=Int%20J%20Cancer&volume=126&issue=10&pages=2437-2447&publication_year=2010&author=Gazzaniga%2CP&author=Naso%2CG&author=Gradilone%2CA&author=Cortesi%2CE&author=Gandini%2CO&author=Gianni%2CW&author=Fabbri%2CMA&author=Vincenzi%2CB&author=di%20Silverio%2CF&author=Frati%2CL&author=Aglian%C3%B2%2CAM&author=Cristofanilli%2CM
- How much income is https://doi.org/10.1158/0008-5472.SABCS-09-3011 earning monthly?
- Get to know what's the income of https://doi.org/10.1038%2Fbjc.1996.600
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8932346?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20polypeptide%20expression%20in%20benign%20and%20malignant%20human%20breast%20lesions%3A%20down-regulation%20of%20cytokeratins&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.1996.600&volume=74&pages=1632-1638&publication_year=1996&author=Franzen%2CB&author=Linder%2CS&author=Alaiya%2CAA&author=Eriksson%2CE&author=Uruy%2CK&author=Hirano%2CT&author=Okuzawa%2CK&author=Auer%2CG?
- https://doi.org/10.1016%2FS0022-5347%2805%2966046-6's revenue stream
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11458120 making per month?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Disseminated%20cytokeratin%20positive%20tumor%20cells%20in%20the%20bone%20marrow%20of%20patients%20with%20prostate%20cancer%3A%20detection%20and%20prognostic%20value&journal=J%20Urol&doi=10.1016%2FS0022-5347%2805%2966046-6&volume=166&pages=699-703&publication_year=2001&author=Weckermann%2CD&author=Muller%2CP&author=Wawroschek%2CF&author=Harzmann%2CR&author=Riethm%C3%BCller%2CG&author=Schlimok%2CG?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14522883 generate monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Molecular%20signature%20associated%20with%20bone%20marrow%20micrometastasis%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=63&pages=5679-5684&publication_year=2003&author=Woelfle%2CU&author=Cloos%2CJ&author=Sauter%2CG&author=Riethdorf%2CL&author=J%C3%A4nicke%2CF&author=Diest%2CP&author=Brakenhoff%2CR&author=Pantel%2CK
- How much does https://doi.org/10.1158%2F1078-0432.CCR-03-0114 earn?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15102669 produce monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=Downregulated%20expression%20of%20cytokeratin%2018%20promotes%20progression%20of%20human%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-03-0114&volume=10&pages=2670-2674&publication_year=2004&author=Woelfle%2CU&author=Sauter%2CG&author=Santjer%2CS&author=Braakenhoff%2CRH&author=Pantel%2CK make?
- What's the monthly money flow for https://doi.org/10.1158%2F1078-0432.CCR-05-0632?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16299229 generate?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Changes%20in%20cytoskeletal%20protein%20composition%20indicative%20of%20an%20epithelial-mesenchymal%20transition%20in%20human%20micrometastatic%20and%20primary%20breast%20carcinoma%20cells&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-0632&volume=11&pages=8006-8014&publication_year=2005&author=Willipinski-Stapelfeldt%2CB&author=Riethdorf%2CS&author=Assmann%2CV&author=Woelfle%2CU&author=Rau%2CT&author=Sauter%2CG&author=Heukeshoven%2CJ&author=Pantel%2CK?
- How much revenue does https://doi.org/10.1023%2FB%3ABREA.0000036787.59816.01 bring in?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15567937?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=High%20Ep-CAM%20expression%20is%20associated%20with%20poor%20prognosis%20in%20node-positive%20breast%20cancer&journal=Breast%20Cancer%20Res%20Treat&doi=10.1023%2FB%3ABREA.0000036787.59816.01&volume=86&pages=207-213&publication_year=2004&author=Spizzo%2CG&author=Went%2CP&author=Dirnhofer%2CS&author=Obrist%2CP&author=Simon%2CR&author=Spichtin%2CH&author=Maurer%2CR&author=Metzger%2CU&author=Castelberg%2CB&author=Bart%2CR&author=Stopatschinskaya%2CS&author=K%C3%B6chli%2COR&author=Haas%2CP&author=Mross%2CF&author=Zuber%2CM&author=Dietrich%2CH&author=Bischoff%2CS&author=Mirlacher%2CM&author=Sauter%2CG&author=Gastl%2CG?
- What's the monthly income of https://doi.org/10.2174%2F156800910791517154?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20384575?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Cancer%20stem%20cells%20and%20epithelial-mesenchymal%20transition%3A%20revisiting%20minimal%20residual%20disease&journal=Curr%20Cancer%20Drug%20Targets&doi=10.2174%2F156800910791517154&volume=10&pages=496-508&publication_year=2010&author=Raimondi%2CC&author=Gianni%2CW&author=Cortesi%2CE&author=Gazzaniga%2CP
- Get to know https://doi.org/10.1016%2Fj.ejca.2010.02.030's earnings
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20303259 earn?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Cancer%20stemness%20and%20metastasis%3A%20therapeutic%20consequences%20and%20perspectives&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2010.02.030&volume=46&pages=1198-1203&publication_year=2010&author=Monteiro%2CJ&author=Fodde%2CR
- Revenue of https://doi.org/10.1158%2F0008-5472.CAN-09-0654
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19584271
- How much profit does http://scholar.google.com/scholar_lookup?&title=The%20emerging%20role%20of%20EpCAM%20in%20cancer%20and%20stem%20cell%20signaling&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-09-0654&volume=69&pages=5627-5629&publication_year=2009&author=Munz%2CM&author=Baeuerle%2CPA&author=Gires%2CO make?
- What's the financial gain of https://citation-needed.springer.com/v2/references/10.1007/s10549-011-1373-x?format=refman&flavour=references?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cristina%20Raimondi?
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cristina%20Raimondi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Angela%20Gradilone each month?
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Angela%20Gradilone%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Giuseppe%20Naso pull in monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Giuseppe%20Naso%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Bruno%20Vincenzi pull in?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Bruno%20Vincenzi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Arianna%20Petracca income
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Arianna%20Petracca%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chiara%20Nicolazzo?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chiara%20Nicolazzo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Antonella%20Palazzo
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Antonella%20Palazzo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rosa%20Saltarelli's earnings
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rosa%20Saltarelli%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Franco%20Spremberg
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Franco%20Spremberg%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Enrico%20Cortesi earns monthly
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Enrico%20Cortesi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Paola%20Gazzaniga have monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Paola%20Gazzaniga%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- How much profit does https://static-content.springer.com/esm/art%3A10.1007%2Fs10549-011-1373-x/MediaObjects/10549_2011_1373_MOESM1_ESM.ppt make?
- How much does https://s100.copyright.com/AppDispatchServlet?title=Epithelial-mesenchymal%20transition%20and%20stemness%20features%20in%20circulating%20tumor%20cells%20from%20breast%20cancer%20patients&author=Cristina%20Raimondi%20et%20al&contentID=10.1007%2Fs10549-011-1373-x©right=Springer%20Science%2BBusiness%20Media%2C%20LLC.&publication=0167-6806&publicationDate=2011-02-05&publisherName=SpringerNature&orderBeanReset=true pull in monthly?
- What's the financial outcome of https://citation-needed.springer.com/v2/references/10.1007/s10549-011-1373-x?format=refman&flavour=citation?
- How profitable is https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research earn?
- https://www.springernature.com/gp/products's total income per month
- How profitable is https://www.springernature.com/gp/librarians?
- How much profit does https://www.springernature.com/gp/societies generate?
- Get to know https://www.springernature.com/gp/partners's earnings
- How much does https://www.springer.com/ net monthly?
- How much cash flow does https://www.nature.com/ have monthly?
- Earnings of https://www.biomedcentral.com/
- How much does https://www.palgrave.com/ generate monthly?
- Monthly income for https://www.apress.com/
- What's the monthly money flow for https://www.springernature.com/gp/legal/ccpa?
- Monthly income for https://www.springernature.com/gp/info/accessibility
- Get to know what's the income of https://support.springernature.com/en/support/home
- What's the profit of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- How much does https://www.springernature.com/ earn?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref